
    
      The objective of this investigation is to capture the followings when Nexium capsules or
      Nexium granules for suspension (single-dose package) are administered to pediatric patients
      in clinical practice after launch.

        1. Development of adverse reactions which are unexpected from Precaution for Use

        2. Development of adverse reactions

        3. Efficacy
    
  